{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1234.47",
  "meta" : {
    "versionId" : "8",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "BEST System Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-06-03"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2021-11-23"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.47",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1234.47"
    }
  ],
  "version" : "20211123",
  "name" : "InfluenzaVaccineHCPCSCodesForExposureIdentification",
  "title" : "Influenza vaccine HCPCS codes for exposure identification",
  "status" : "retired",
  "experimental" : false,
  "date" : "2021-11-23T01:02:05-05:00",
  "publisher" : "BEST System Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: Influenza vaccine HCPCS codes for identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Procedure/Intervention, Immunization, Medication, or Substance.),(Inclusion Criteria: Influenza vaccine HCPCS codes.),(Exclusion Criteria: None)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "concept" : [
          {
            "code" : "G0008",
            "display" : "Administration of influenza virus vaccine"
          },
          {
            "code" : "G9141",
            "display" : "Influenza a (h1n1) immunization administration (includes the physician counseling the patient/family)"
          },
          {
            "code" : "G9142",
            "display" : "Influenza a (h1n1) vaccine, any route of administration"
          },
          {
            "code" : "Q2033",
            "display" : "Influenza vaccine, recombinant hemagglutinin antigens, for intramuscular use (flublok)"
          },
          {
            "code" : "Q2034",
            "display" : "Influenza virus vaccine, split virus, for intramuscular use (agriflu)"
          },
          {
            "code" : "Q2035",
            "display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)"
          },
          {
            "code" : "Q2036",
            "display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)"
          },
          {
            "code" : "Q2037",
            "display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)"
          },
          {
            "code" : "Q2038",
            "display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)"
          },
          {
            "code" : "Q2039",
            "display" : "Influenza virus vaccine, not otherwise specified"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:2ef4cf4d-f630-4d25-b625-7ec11f74c2dd",
    "timestamp" : "2024-06-14T14:38:33-04:00",
    "total" : 7,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "G0008",
        "display" : "Administration of influenza virus vaccine"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "Q2034",
        "display" : "Influenza virus vaccine, split virus, for intramuscular use (agriflu)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "Q2035",
        "display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "Q2036",
        "display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "Q2037",
        "display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "Q2038",
        "display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version" : "2024",
        "code" : "Q2039",
        "display" : "Influenza virus vaccine, not otherwise specified"
      }
    ]
  }
}
